Skip to main content
HCA
NYSE Industrial Applications And Services

Director & 10% Owner William Frist Restructures Significant HCA Stake

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Healthcare Facility Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$502.05
Mkt Cap
$114.532B
52W Low
$295
52W High
$527.555
52W Position info
70% above low
Off High info
4.8% below high
Rel. Volume info
0.6× avg
Market data snapshot near publication time

HCA sits 70% above its 52-week low of $295.

Summary

William R. Frist, a Director and 10% Owner of HCA Healthcare, reported a substantial reorganization of his indirect holdings, involving an exchange of shares and a conversion of an associated entity to a partnership for tax purposes.


Key Events · Ownership and Investor Activity · HCA

  • Major Ownership Restructuring

    William R. Frist, through Frisco Holding II, engaged in a reorganization involving the disposition of 36,629,188 shares and the acquisition of 36,557,141 newly issued shares of HCA Healthcare.

  • Tax-Driven Reorganization

    The transaction, occurring on February 6, 2026, constituted a reorganization for U.S. federal income tax purposes, including the conversion of Frisco Holding II to a partnership.

  • Significant Value Involved

    The total value of shares exchanged in this reorganization was approximately $36.7 billion, representing a substantial portion of the company's market capitalization.

  • Net Share Change

    The reorganization resulted in a net disposition of 72,047 shares by Frisco Holding II.


Analysis · HCA · Industrial Applications And Services

This Form 4 filing details a significant, albeit complex, restructuring of indirect ownership by William R. Frist, a key Director and 10% Owner of HCA Healthcare. The transaction, coded 'J' for "Other Acquisition/Disposition," involved an exchange of shares and a tax-driven reorganization of Frisco Holding II, an entity associated with the Frist family. While the net change in shares disposed is relatively small, the sheer volume of shares involved in the exchange (approximately 32% of HCA's market capitalization) highlights a major structural adjustment in how a significant block of the company's equity is held. Investors should note this as a change in the long-term ownership structure by a foundational shareholder group, rather than a direct signal of operational performance or a typical open-market sale.

At the time of this filing, HCA was trading at $502.05 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $114.5B. The 52-week trading range was $295.00 to $527.55. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

HCA - Latest Insights

HCA
Jul 24, 2026, 8:13 AM EDT
Source: dpa-AFX
Importance Score:
7
Price at Filing: $379.20
Real-time Price: $377.42 info
Change: -$1.78 (-0.47%) info
Market Cap: $84.785B info
HCA
Jul 24, 2026, 7:57 AM EDT
Source: dpa-AFX
Importance Score:
8
Price at Filing: $369.00
Real-time Price: $377.42 info
Change: +$8.42 (+2%) info
Market Cap: $84.785B info
HCA
Jul 24, 2026, 7:45 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $369.00
Real-time Price: $377.42 info
Change: +$8.42 (+2%) info
Market Cap: $84.785B info
HCA
Jul 24, 2026, 7:43 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $369.00
Real-time Price: $377.42 info
Change: +$8.42 (+2%) info
Market Cap: $84.785B info
HCA
Jul 20, 2026, 7:21 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $385.55
Real-time Price: $377.42 info
Change: -$8.13 (-2%) info
Market Cap: $84.785B info